The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
163 MICROPET IMAGING OF [18F]-DFNSH IN RAT BRAIN:<br />
A RADIOLIGAND FOR KETAMINE-INDUCED<br />
NEURONAL DEATH.<br />
X. Zhang 1 , M. G. Paule 1 , G. D. Newport 1 , X. Zou 1 , N. Sadovova 2 , M. S.<br />
Berridge 3 , S. M. Apana 3 , G. Kabalka 4 , W. Slikker 1 and C. Wang 1 . 1 Division <strong>of</strong><br />
Neurotoxicology, NCTR/FDA, Jefferson, AR, 2 Toxicologic Pathology Associates,<br />
Jefferson, AR, 3 3D Imaging, LLC, Little Rock, AR and 4 <strong>The</strong> University <strong>of</strong> Tennessee,<br />
Knoxville, TN.<br />
Recent reports indicate that 6-12 hours <strong>of</strong> ketamine anesthesia triggers neuronal<br />
apoptosis in postnatal day (PND) 7 rats. In vitro, ex vivo and confocal fluorescent<br />
imaging studies suggest that the dansyl compounds can accumulate within the cytoplasm<br />
<strong>of</strong> the apoptotic cell. High-resolution positron emission tomography<br />
(microPET) imaging has been proposed as a minimally invasive method for detecting<br />
apoptosis in the rat brain. Compared with the [18F]-labeled annexin V, which<br />
binds to externalized phosphatidylserine (PS) on the outer membrane <strong>of</strong> apoptotic<br />
cells, intracellular uptake <strong>of</strong> the dansylhydrazone <strong>of</strong> p-fluorobenzaldehyde<br />
(DFNSH) may lead to improved target to background contrast ratios. In this study,<br />
the effect <strong>of</strong> ketamine on the uptake and retention <strong>of</strong> [18F]-DFNSH in the rat<br />
brain was investigated using microPET imaging. On PND-7, rat pups in the experimental<br />
group were exposed to 6 subcutaneous injections <strong>of</strong> ketamine and control<br />
rat pups received 6 injections <strong>of</strong> saline. On PND-35, [18F]-DFNSH (37 MBq)<br />
was injected into the tail vein <strong>of</strong> rats and microPET images were obtained over 2<br />
hours following the injection. Radiolabeled tracer accumulation in the region <strong>of</strong> interest<br />
(ROI) in the frontal cortex was converted into Standard Uptake Values<br />
(SUVs). After the injection, radiotracer was quickly distributed into the brains <strong>of</strong><br />
both ketamine- and saline-treated rats. Compared with the control group, the uptake<br />
<strong>of</strong> [18F] -DFNSH was significantly increased in the ROI <strong>of</strong> ketamine-treated<br />
rats. Additionally, the duration for wash-out <strong>of</strong> the tracer was prolonged in the ketamine-treated<br />
animals. This preliminary study demonstrates that microPET imaging<br />
is capable <strong>of</strong> distinguishing differences in retention <strong>of</strong> [18F] -DFNSH in different<br />
brain regions and suggests that this approach may provide a minimally invasive<br />
biomarker <strong>of</strong> neuronal apoptosis.<br />
Supported by NCTR/FDA, E7264<br />
164 IN VITRO ASSESSMENT OF DEVELOPMENTAL<br />
NEUROTOXICITY: USE OF MICROELECTRODE<br />
ARRAYS TO MEASURE FUNCTIONAL CHANGES IN<br />
NEURONAL NETWORK ONTOGENY.<br />
B. Robinette, W. R. Mundy and T. J. Shafer. ISTD, U.S. EPA, Research Triangle<br />
Park, NC .<br />
Because the Developmental Neurotoxicity Testing Battery requires large numbers<br />
<strong>of</strong> animals and is expensive, development <strong>of</strong> in vitro approaches to screen chemicals<br />
for potential developmental neurotoxicity is a high priority. Many proposed approaches<br />
for screening are biochemical, and do not assess function in networks <strong>of</strong><br />
interconnected neurons. In this study, microelectrode arrays (MEAs) were used to<br />
determine if chemical-induced changes in function could be detected by assessing<br />
the development <strong>of</strong> spontaneous network activity. MEAs record individual action<br />
potential spikes as well as groups <strong>of</strong> spikes (bursts) in neuronal networks, and activity<br />
can be assessed repeatedly over days in vitro (DIV). Primary cultures <strong>of</strong> cortical<br />
neurons were prepared on MEAs and spontaneous activity was assessed on DIV 2,<br />
6, 9, 13, and 20 to determine the in vitro developmental pr<strong>of</strong>ile <strong>of</strong> spontaneous<br />
spiking and bursting in cortical networks. In addition 2.5 or 5 μM <strong>of</strong> the PKC inhibitor<br />
bisindolylmaleamide (BIS) was added to MEAs (n= 7-10) on DIV5 to determine<br />
if changes in spontaneous activity could be detected in response to inhibition<br />
<strong>of</strong> neurite outgrowth. A clear pr<strong>of</strong>ile <strong>of</strong> in vitro activity development occurred<br />
in control MEAs, with the number <strong>of</strong> active channels increasing from 0/MEA on<br />
DIV2 to 46±5/MEA by DIV13; the rate <strong>of</strong> increase was most rapid between DIV<br />
6 and 13, and activity declined by DIV 20. A similar pattern was observed for the<br />
number <strong>of</strong> bursting channels, as well as the total number <strong>of</strong> bursts. BIS caused a<br />
concentration-dependent decrease in the number <strong>of</strong> active channels/MEA, the<br />
number <strong>of</strong> bursting channels/MEA the number <strong>of</strong> bursts/channel and the number<br />
<strong>of</strong> individual spikes on bursting channels. Other burst characteristics, such as burst<br />
duration and the number <strong>of</strong> spikes in a burst, were unchanged by BIS. <strong>The</strong>se results<br />
demonstrate that MEAs can be used to assess the development functional neuronal<br />
networks in vitro, as well as chemical-induced dysfunction. (This abstract does not<br />
reflect Agency policy).<br />
165 EVALUATING ALTERATIONS IN ZEBRAFISH RETINO-<br />
TECTAL PROJECTIONS AS AN INDICATION OF<br />
DEVELOPMENTAL NEUROTOXICITY.<br />
J. Cowden 1, 2 , C. Fan 1, 3 , D. Hunter 1 , B. Padnos 1 , K. Jensen 1 , R.<br />
Ramabhadran 1 and S. Padilla 1 . 1 Integrated Systems <strong>Toxicology</strong> Division, U.S. EPA,<br />
Durham, NC, 2 National Center for Environmental Assessment, U.S. EPA, Durham,<br />
NC and 3 Syngenta Biotechnology Inc., Durham, NC.<br />
<strong>The</strong> U.S. EPA is developing alternative screening methods to identify putative developmental<br />
neurotoxicants and prioritize chemicals for additional testing. One<br />
method developmentally exposes zebrafish embryos and assesses nervous system<br />
structure at 2 days post fertilization (dpf). Previous data indicated that exposure to<br />
developmental neurotoxicants reduced retino-tectal projection area. To determine<br />
if altered retino-tectal projection area is a useful endpoint for assessing developmental<br />
neurotoxicity, zebrafish embryos were exposed four chemicals (retinoic acid,<br />
cadmium, valproate, and ethanol) with evidence <strong>of</strong> developmental neurotoxicity in<br />
mammalian systems, and three chemicals (saccharin, amoxicillin, and omeprazole)<br />
without such evidence. All experiments were conducted in 96-well plates at 26 o C.<br />
Zebrafish embryos were exposed to a range <strong>of</strong> chemical sublethal concentrations<br />
from 6 hours to 2 dpf. At 2 dpf nervous system structure was examined by whole<br />
mount anti-acetylated α-tubulin staining and retino-tectal projection area was<br />
measured. All measurements were made blinded to dose. Of the chemicals examined,<br />
valproate, ethanol, and retinoic acid showed a dose-dependent decrease in<br />
retino-tectal projection area. Furthermore, quantitative real-time PCR (qRT-PCR)<br />
demonstrated that exposure to valproate or ethanol alters levels <strong>of</strong> brn3c, a transcription<br />
factor important for optic tectum development. <strong>The</strong>se preliminary results<br />
suggest that changes in retino-tectal projection area may correlate with developmental<br />
neurotoxicity in mammals and such changes might be measured rapidly<br />
using qRT-PCR. <strong>The</strong> contents <strong>of</strong> this abstract do not necessarily reflect the views <strong>of</strong><br />
the U.S. EPA, nor does mention <strong>of</strong> trade names or commercial products constitute<br />
endorsement or recommendation for use.<br />
166 METHYLPHENIDATE: A THREE-YEAR ASSESSMENT<br />
ON COMPLEX BRAIN FUNCTION IN JUVENILE<br />
RHESUS MONKEYS.<br />
T. A. Patterson 1 , M. Li 1 , S. M. Morris 1 , N. C. Twaddle 1 , D. R. Doerge 1 , W.<br />
Slikker 1 , D. R. Mattison 2 and M. G. Paule 1 . 1 NCTR/FDA, Jefferson, AR and<br />
2<br />
NICHD, Rockville, MD.<br />
Methylphenidate (MPH) is a prescribed stimulant for the treatment <strong>of</strong> attentiondeficit<br />
hyperactivity disorder (ADHD), and the widespread use <strong>of</strong> MPH continues<br />
to raise concern about its safety. This study examined the ability <strong>of</strong> juvenile rhesus<br />
monkeys to perform complex behavioral tasks contained in the NCTR Operant<br />
Test Battery (OTB) during treatment with MPH that produced clinically-relevant<br />
blood levels. Monkeys (n=10/group) were treated orally (2x/day – morning and afternoon<br />
(M-F)) with either 0.5 ml/kg vehicle (CON group), 2.5 mg/kg MPH (LD<br />
group), or 12.5 mg/kg MPH (HD group). This dosing regimen provided MPH<br />
plasma levels near human therapeutic values (LD group) and five-to-ten times<br />
human therapeutic values (HD group). OTB testing (50 minutes/day (M-F))<br />
began 30 minutes after the morning dose and required the monkeys to press levers<br />
or press-plates to receive food-pellet reinforcers. <strong>The</strong> OTB includes Progressive<br />
Ratio (PR), Conditioned Position Responding (CPR) and Incremental Repeated<br />
Acquisition (IRA) tasks, which assess aspects <strong>of</strong> motivation, color-position discrimination<br />
and learning, respectively. Response Rate (RR), Percent Task Completed<br />
(PTC), and Accuracy (ACC) serve as performance metrics. With the exception <strong>of</strong><br />
elevated serum alanine aminotransferase (ALT) in the HD group, there were no remarkable<br />
alterations in other health bio-monitoring parameters. However, there<br />
was a significant dose response <strong>of</strong> MPH on behavior. Monkeys in the HD group<br />
performed much more poorly than the LD or CON groups. <strong>The</strong> HD group lagged<br />
well behind in task acquisition and had much lower scores for PTC, RR and ACC<br />
in all tasks. MPH is a known appetite suppressant, therefore, much <strong>of</strong> these effects<br />
could stem from a decreased motivation to perform, although effects on ACC suggest<br />
other mechanisms. Supported in part by the Best Pharmaceuticals for Children<br />
Act 2002 and 2007.<br />
SOT 2010 ANNUAL MEETING 35